Physician profile
Mark A Wells
NPI 1992281075
$880.03
in general payments reported to CMS, 2019-2025
10 companies · $25.25 in 2025
The $25.25 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.29 · 2020: $125 · 2021: $108 · 2022: $126 · 2023: $316 · 2024: $108 · 2025: $25.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351 · Education: $99.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.92 |
| Education | $99.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $353.27 | 2019-2024 | Invisalign |
| Kerr Corporation | $172.69 | 2022-2023 | Nexus Rmgi, Zirconia Abutment Preparation Kit |
| Nobel Biocare USA | $120.52 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $89.17 | 2019-2024 | Arestin |
| Envista Holdings Corporation | $44.64 | 2024 | Optibond Solo Plus |
| Dentsply Sirona INC | $26.09 | 2022 | |
| Biohorizons Implant Systems INC. | $25.25 | 2025 | Biohorizons Dental Implants |
| Implant Direct Sybron International LLC | $18.45 | 2019 | |
| Voco America INC. | $15.53 | 2024 | Grandio So Heavy Flow, Meron Plus Qm, Admira Fusion X-Tra |
| Zimmer Biomet Holdings, INC. | $14.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.